Delivery Order SPE2DX22D0040-SPE2D826FA1FL
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,248.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract, issued on November 2, 2025, with completion targeted for November 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and reflects AmerisourceBergen's established capability to supply critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,069.20 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed-price, non-set-aside contract under which AmerisourceBergen will deliver pharmaceutical products and medical supplies to support federal medical procurement needs. The award represents a child delivery order issued under a larger contract vehicle, reflecting...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $423,150 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive, non-set-aside award was issued on October 6, 2025, with an ultimate completion date of October 7, 2025. The contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $51,016.44 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract represents a child award under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $15,443.12 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The award was made on a non-set-aside, competitive basis to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $94,752.62 to AmerisourceBergen Drug Corp on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was made on a competitive basis without set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,865.12 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania. This non-competitive, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 6, 2025. This firm fixed-price delivery order, valued at $27,760.32 with an ultimate completion date of September 8, 2025, was awarded on a competitive basis without set-aside designations. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $980,600.53 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $60,450 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of November 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DX22D0040Indefinite Delivery Contract
- SPE2DX22D0040-SPE2D826FA1FLDelivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 10, 2025. The contract is a firm fixed-price delivery order with a ceiling value of $1,363.11 and an ultimate completion date of November 12, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The delivery order was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's typical federal procurement awards. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Through its prime IDC vehicle, the company provides diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical devices to customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contract awards and competitive track record demonstrate its capability to meet federal medical supply requirements across multiple therapeutic domains and geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/10/25 |